• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

涎腺和泪腺及乳腺腺样囊性癌:同一肿瘤不同的临床结局。

Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor.

机构信息

Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil; Department of Pathology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas, Sao Paulo, Brazil; Department of Periodontics and Oral Medicine, Laboratory of Epithelial Biology, University of Michigan School of Dentistry, Ann Arbor, MI, USA.

Department of Pathology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas, Sao Paulo, Brazil.

出版信息

Crit Rev Oncol Hematol. 2022 Nov;179:103792. doi: 10.1016/j.critrevonc.2022.103792. Epub 2022 Aug 13.

DOI:10.1016/j.critrevonc.2022.103792
PMID:35973662
Abstract

Adenoid cystic carcinoma (ACC) is a biphasic malignant lesion that can develop at various anatomical sites. Salivary and lacrimal ACC lesions have a high risk of local invasion, metastasis, and poor prognosis. In more distant organs, such as the breast, ACC is a rarer and less aggressive lesion. One of the major predictors of mortality of ACC is perineural invasion, which can be seen in 30 % of breast lesions, 85% of salivary lesions, and almost 100 % of lacrimal gland tumors. The biological differences between these three ACC tumors are still poorly understood. We focused on the current understanding of the genetic variations observed on ACC tumors and prognostic differences associated with distinct anatomical sites. A special effort was made to present the currently available therapies alongside the emerging strategies under development.

摘要

腺样囊性癌(ACC)是一种双相恶性病变,可发生在各种解剖部位。唾液腺和泪腺的 ACC 病变具有较高的局部侵袭、转移和预后不良的风险。在更远的器官,如乳房,ACC 是一种罕见的侵袭性较低的病变。ACC 死亡的主要预测因素之一是神经周围侵犯,在 30%的乳房病变、85%的唾液腺病变和几乎 100%的泪腺肿瘤中可见。这三种 ACC 肿瘤之间的生物学差异仍知之甚少。我们重点介绍了目前对 ACC 肿瘤观察到的遗传变异的理解,以及与不同解剖部位相关的预后差异。特别努力介绍了目前可用的治疗方法以及正在开发的新策略。

相似文献

1
Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor.涎腺和泪腺及乳腺腺样囊性癌:同一肿瘤不同的临床结局。
Crit Rev Oncol Hematol. 2022 Nov;179:103792. doi: 10.1016/j.critrevonc.2022.103792. Epub 2022 Aug 13.
2
Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.涎腺、泪腺和乳腺的腺样囊性癌在形态和遗传学上相似,但具有不同的 microRNA 表达谱。
Mod Pathol. 2018 Aug;31(8):1211-1225. doi: 10.1038/s41379-018-0005-y. Epub 2018 Feb 21.
3
Adenoid cystic carcinoma of salivary and lacrimal gland origin: localization, classification, clinical pathological correlation, treatment results and long-term follow-up control in 84 patients.涎腺和泪腺来源的腺样囊性癌:84例患者的定位、分类、临床病理相关性、治疗结果及长期随访
Anticancer Res. 2003 Mar-Apr;23(2A):931-40.
4
Lacrimal Gland Adenocarcinoma Clinicopathologic Features and Outcomes Compared With Those of Lacrimal Gland Adenoid Cystic Carcinoma.泪腺腺癌的临床病理特征和结局与泪腺腺样囊性癌的比较。
Ophthalmic Plast Reconstr Surg. 2024;40(4):419-425. doi: 10.1097/IOP.0000000000002606. Epub 2024 Jul 3.
5
Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.泪腺腺样囊性癌常以MYB重排为特征。
Eye (Lond). 2017 May;31(5):720-725. doi: 10.1038/eye.2016.307. Epub 2017 Jan 13.
6
Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.泪腺腺样囊性癌治疗中的多模态疗法
BMC Ophthalmol. 2019 Jun 8;19(1):125. doi: 10.1186/s12886-019-1110-5.
7
Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma.Notch1受体及临床病理高危预测因素在泪腺腺样囊性癌中的预后影响
Acta Ophthalmol. 2021 Dec;99(8):e1467-e1473. doi: 10.1111/aos.14812. Epub 2021 Mar 6.
8
Expression of metabolism-related proteins in lacrimal gland adenoid cystic carcinoma.泪腺腺样囊性癌中代谢相关蛋白的表达
Am J Clin Pathol. 2015 Apr;143(4):584-92. doi: 10.1309/AJCPXAYH10WENLTC.
9
Adenoid cystic carcinoma of the lacrimal sac: case report.泪囊腺样囊性癌:病例报告
Arq Bras Oftalmol. 2016 Sep-Oct;79(5):333-335. doi: 10.5935/0004-2749.20160095.
10
Vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1 alpha (HIF-1ɑ) in lacrimal gland Adenoid cystic carcinoma: Correlation with clinical outcome.泪腺腺样囊性癌中血管内皮生长因子(VEGF)和缺氧诱导因子-1α (HIF-1ɑ):与临床结果的相关性。
Ann Diagn Pathol. 2022 Feb;56:151846. doi: 10.1016/j.anndiagpath.2021.151846. Epub 2021 Oct 29.

引用本文的文献

1
Assessing the selective impact of histone modifying drugs on adenoid cystic carcinoma cells and their stem cell counterparts.评估组蛋白修饰药物对腺样囊性癌细胞及其干细胞对应物的选择性影响。
BMC Cancer. 2025 Aug 7;25(1):1277. doi: 10.1186/s12885-025-14739-z.
2
Proliferation and migration inhibition of adenoid cystic carcinoma cells through autophagy suppression via GLUT1 knockdown.通过敲低GLUT1抑制自噬对腺样囊性癌细胞增殖和迁移的抑制作用
Heliyon. 2025 Feb 20;11(4):e42894. doi: 10.1016/j.heliyon.2025.e42894. eCollection 2025 Feb 28.
3
Cell culture in salivary gland tumor research: molecular insights of pathogenic targets and personalized medicine.
唾液腺肿瘤研究中的细胞培养:致病靶点的分子见解与个性化医疗
Cytotechnology. 2025 Apr;77(2):70. doi: 10.1007/s10616-025-00726-6. Epub 2025 Feb 27.
4
Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers.尽管缺乏常规生物标志物,个性化免疫疗法在转移性腺样囊性癌中实现完全缓解。
Curr Oncol. 2024 Sep 29;31(10):5838-5849. doi: 10.3390/curroncol31100434.
5
Molecular Analysis of Salivary and Lacrimal Adenoid Cystic Carcinoma.唾液腺和泪腺腺样囊性癌的分子分析
Cancers (Basel). 2024 Aug 17;16(16):2868. doi: 10.3390/cancers16162868.
6
Prognostic factors for lacrimal gland adenoid cystic carcinoma: a retrospective study in Chinese patients.泪腺腺样囊性癌的预后因素:一项针对中国患者的回顾性研究。
Int J Ophthalmol. 2024 Aug 18;17(8):1423-1430. doi: 10.18240/ijo.2024.08.06. eCollection 2024.
7
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade.系统治疗在唾液腺腺样囊性癌转移或局部复发中的应用:过去十年的系统评价。
Br J Cancer. 2024 Oct;131(6):1021-1031. doi: 10.1038/s41416-024-02795-4. Epub 2024 Aug 3.
8
Prognosis of primary breast salivary gland-type carcinoma: a propensity score-matching analysis with invasive carcinoma of no special type based on the SEER database for years 2010-2020.基于 2010-2020 年 SEER 数据库,采用倾向评分匹配分析对原发性乳腺涎腺型癌的预后:与非特殊型浸润性癌的比较。
Breast Cancer. 2024 May;31(3):496-506. doi: 10.1007/s12282-024-01564-8. Epub 2024 Mar 28.
9
Treatment of lacrimal gland adenoid cystic carcinoma: a systematic review and Meta-analysis.泪腺腺样囊性癌的治疗:一项系统评价和Meta分析。
Int J Ophthalmol. 2024 Jan 18;17(1):164-172. doi: 10.18240/ijo.2024.01.22. eCollection 2024.
10
Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population-based analysis.原发性泪腺恶性肿瘤的发病率、临床特征和生存结局:一项基于人群的分析。
Cancer Med. 2024 Feb;13(3):e6831. doi: 10.1002/cam4.6831. Epub 2024 Jan 17.